Evidence map›Paper›PMID 38027882›Full record

ArticleHeliyon2023

Exploring the anticancer potential of Actinidia chinensis Planch root extracts (

Kaijie Qiu, Qing Xia, Hao Chen, Qiong Ye, Haixiang Mao, Mei Tian, Yichao Gan, Qinyuan Huang, Haibiao Wang, Shiwei Duan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Frontiers in pharmacology · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kaijie QiuDepartment of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, 315048, China.
Qing XiaCollege of Pharmacy, Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, China.
Hao ChenDepartment of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, 315048, China.
Qiong YeDepartment of Orthopaedic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, 315048, China.
Haixiang MaoDepartment of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, 315048, China.
Mei TianCollege of Pharmacy, Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, China.
Yichao GanDepartment of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, 315048, China.
Qinyuan HuangKey Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, 310014, China.
Haibiao WangDepartment of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, 315048, China.
Shiwei DuanKey Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, 310014, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC), ranking as the seventh most prevalent cancer worldwide, poses a significant health challenge.

Indexed as

Actinidia chinensis planch Root extracts (acRoots)AKT/mTOR signalingAnticancer efficacyApoptosisAutophagyHepatocellular carcinoma

Identifiers

PMID38027882
PMCPMC10656260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.